Comment on

• Pelvic inflammatory disease. Key treatment issues and options.

  Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Peterson HB, et al. JAMA. 1991 Nov 13;266(18):2605-11. doi: 10.1001/jama.266.18.2605. JAMA. 1991. PMID: 1658404 Review.
• Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model.

  Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Kahn JG, et al. JAMA. 1991 Nov 13;266(18):2594-604. doi: 10.1001/jama.266.18.2594. JAMA. 1991. PMID: 1834868 Review.
• Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.

  Washington AE, Katz P. Washington AE, et al. JAMA. 1991 Nov 13;266(18):2565-9. JAMA. 1991. PMID: 1942401
• Self-reported pelvic inflammatory disease in the United States, 1988.

  Aral SO, Mosher WD, Cates W Jr. Aral SO, et al. JAMA. 1991 Nov 13;266(18):2570-3. JAMA. 1991. PMID: 1942402
• Assessing risk for pelvic inflammatory disease and its sequelae.

  Washington AE, Aral SO, Wølner-Hanssen P, Grimes DA, Holmes KK. Washington AE, et al. JAMA. 1991 Nov 13;266(18):2581-6. JAMA. 1991. PMID: 1942404 Review.
• Pathogenesis of pelvic inflammatory disease. What are the questions?

  Rice PA, Schachter J. Rice PA, et al. JAMA. 1991 Nov 13;266(18):2587-93. JAMA. 1991. PMID: 1942405 Review.